PHA Canada is the link between your voice and decision makers. By continuing to advocate for patients, we are trying to ensure that any changes to these complicated regulatory processes will not negatively impact patients’ ability to access new therapies in the future. Back to Advocate
Read PHA Canada’s latest submissions to the Patented Medicines Pricing Review Board (PMPRB) December 2022 March 2021 February 2020 August 2020